Commentary / World Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn’t deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug "accelerated approval.”
